InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
16
T+90 hit rate
0%
T+90 mean return
-20.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Zawel Leigh. Director active across 1 company, notably Cullinan Oncology, Inc.. Cumulatively, 17 disclosures have been recorded. Split: 0 buy · 16 sells. Total volume traded: €7.1m. Activity tracked since 9 August 2021. The latest transaction was disclosed on 11 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations17 total
32,500 shares0Common StockSEC:0000899243-22-006417:0
19,574 shares@ US$25.000.044% mcap5.9% of flowCommon StockSEC:0000899243-21-040453:0
19,574 shares@ US$25.005.9% of flowCommon StockSEC:0000899243-21-040453
1,079 shares@ US$25.000.3% of flowCommon StockSEC:0000899243-21-039858
1,079 shares@ US$25.000.0024% mcap0.3% of flowCommon StockSEC:0000899243-21-039858:0
7,468 shares@ US$25.160.017% mcap2.2% of flowCommon StockSEC:0000899243-21-036781:0
7,468 shares@ US$25.162.2% of flowCommon StockSEC:0000899243-21-036781
28,118 shares@ US$28.959.6% of flowCommon StockSEC:0000899243-21-035331
28,118 shares@ US$28.950.071% mcap9.6% of flowCommon StockSEC:0000899243-21-035331:0
28,118 shares@ US$29.000.072% mcap9.7% of flowCommon StockSEC:0000899243-21-034311:0
28,118 shares@ US$29.009.7% of flowCommon StockSEC:0000899243-21-034311
19,504 shares@ US$26.520.046% mcap6.2% of flowCommon StockSEC:0000899243-21-034314:0
19,504 shares@ US$26.526.2% of flowCommon StockSEC:0000899243-21-034314
28,118 shares@ US$29.000.072% mcap9.7% of flowCommon StockSEC:0000899243-21-034027:0
28,118 shares@ US$29.009.7% of flowCommon StockSEC:0000899243-21-034027
19,504 shares@ US$26.520.046% mcap6.2% of flowCommon StockSEC:0000899243-21-032515:0
19,504 shares@ US$26.526.2% of flowCommon StockSEC:0000899243-21-032515
17 of 17 declarations
About Zawel Leigh
Zawel Leigh is an executive at Cullinan Oncology, Inc.
